Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer’s Disease: Role of CCL2

Overview of attention for article published in Molecular Neurobiology, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 42 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.

Alzforum, 19 Jul 2019

Gutiérrez IL, González-Prieto M, Caso JR, García-Bueno B, Leza JC, Madrigal JL.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.